학술논문
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).
Document Type
Article
Author
Source
Human Vaccines & Immunotherapeutics; 2022, Vol. 18 Issue 1, p1-14, 14p
Subject
Language
ISSN
21645515